Inhibition of cardiac ATP-dependent potassium channels by sulfonylurea drugs

Current Opinion in Investigational Drugs

Volumn 2, Issue 1, 2001, Pages 72-80

  Gogelein H ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Action potential duration; Heart muscle cell; Ischemia; KATP channel; Sulfonylurea drug

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AZIMILIDE; CLAMIKALANT; DOFETILIDE; GLIBENCLAMIDE; LEMAKALIM; N [4 [1 HYDROXY 2 [4 (4 PYRIDYL) 1 PIPERAZINYL]ETHYL]PHENYL]METHANESULFONAMIDE; PAMIDRONIC ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RILMAKALIM; SOTALOL; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE;

ACTION POTENTIAL; CORONARY ARTERY OBSTRUCTION; DOG; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; HYPOXIA; INHIBITION KINETICS; ISCHEMIA; ISOLATED ORGAN; NONHUMAN; OOCYTE; RABBIT; REVIEW; ST SEGMENT; SWINE; XENOPUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZAMIDES; HEART; HUMANS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; SULFONYLUREA COMPOUNDS;

EID: 0035148286     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. KATP: An inward rectifier subunit plus the sulfonylurea receptor
2. ATP channel subunits
3. ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies
4. Membrane current through adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells
5. Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide
6. Ionic currents during hypoxia in voltage-clamped cat ventricular muscle
7. The shortening of the action potential by DNP in guinea pig ventricular myocytes is mediated by an increase of a time-independent K conductance
8. Potassium channels in isolated patches of cardiac cell membrane
9. + channels in cardiac muscle
10. Inward-rectifying channels in isolated patches of the heart cell membrane: ATP-dependence and comparison with cell-attached patches
11. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction
12. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction
13. Channel 'selectivity' and evolution. Has evolutionary pressure and natural selection provided the ATP sensitive potassium channel in the myocardium as an endogenous protection against ischaemic heart disease?
14. The pharmacology of ATP-sensitive potassium channels
15. Recent progress in potassium channel opener pharmacology
16. Properties and functions of ATP-sensitive K-channels
17. ATP channels by glibenclamide in rat ventricular myocytes
18. Potassium accumulation in the globally ischemic mammalian heart
19. + channels during metabolic stress in cardiac muscle
20. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle
21. ATP channels
22. + channels toward sulfonylureas
23. ATP channel by glyburide and 5-hydroxydecanoate
24. Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection?
25. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: Effects on cardiomyocytes, coronary flow and pancreatic β-cells
26. ATP channels
27. ATP channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits
28. ATP channel in preservation of mitochondrial function
29. Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle
30. Reducing electrical defibrillation threshholds with glibenclamide in an isolated rabbit heart preparation
31. Modification by glibenclamide of the electrophysiological consequences of myocardial ischemia in dogs and rabbits
32. Attenuation by phentolamine of hypoxia and levcromakalim-induced abbreviation of the cardiac action potential
33. ATP channels in coronary perfused ventricular muscles of guinea-pigs
34. ATP channels limits energy depletion in the guinea pig heart
35. ATP channels
36. + channel blockers on the action potential shortening in hypoxic and ischaemic myocardium
37. + channel openers
38. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia
39. ATP channel modulators and myocardial damages induced by ischemia-reperfusion: Membrane lipids injury and arrhythmias
40. + channels protect the myocardium against ischemia/reperfusion damage
41. + channels in the early phase of reperfusion and its protective role against myocardial stunning
42. Glibenclamide, but not class III drugs, prevents ischaemic shortening of the refractory period in guinea-pig hearts
43. Effects of glucose and glibenclamide on hypoxic myocardium: Electric and mechanical function, CK-release and irreversible cell damage
44. Effekte von Glucose und Glibenclamid am isolierten hypoxischen Herzen. Elektrophysiologische, funktionelle, biochemische und quantitativ histologische Untersuchungen
45. KATP blockers glibenclamide and HMR 1883 on cardiac electrophysiology during regional ischaemia and reperfusion
46. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbit but reduces ischemia-induced arrhythmias
47. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart
48. Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: A study with cromakalim, 5-hydroxydecanoate and glibenclamide
49. ATP channels and basal coronary vascular tone
50. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine
51. ATP channels
52. ATP channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs
53. ATP channels: An endogenous protective mechanism during repetitive ischemia
54. Shortening of monophasic action potential duration during hyperkalemia and myocardial ischemia in anesthetized dogs
55. Glibenclamide attenuates peaked T wave in early phase of myocardial ischemia
56. + channel on ECG ST segment elevation during a bout of myocardial ischemia: A study on epicardial mapping in dogs
57. HMR-1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs
58. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death
59. The effects of the ATP-dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs
60. Ks blockade in the prevention of ischaemic ventricular fibrillation after myocardial infarction
61. Do animal models have clinical value?
62. ATP channels: An endogenous protective mechanism during repetitive ischemia
63. ATP channel blocker HMR 1883 attenuates the effects of ischaemia on MAP duration and improves survival during LAD occlusion in the anaesthetized pig
64. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts
65. Potassium channel openers and blockers: Do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts
66. ATP-sensitive potassium channel modulators: Both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats
67. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts
68. + channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation
69. + channels and lactate-coupled efflux
70. + channels in cardiac ischemia: An endogenous mechanism for protection of the heart
71. ATP channel modulation in working rat hearts with coronary occlusion: Effects of cromakalim, cicletanine, and glibenclamide
72. ATP channel blocker, and its prevention by levcromokalim and insulin
73. 1-receptor stimulation
74. 1-receptors
75. Involvement of ATP-sensitive potassium channels in preconditioning protection
76. + channels and myocardial preconditioning
77. + channel openers?
78. ATP channels in ischemic cardioprotection
79. + channels in cardiac muscle from cold-acclimated goldfish: Characterization and altered response to ATP
80. Glibenclamide binding in vertebrate cardiac membranes
81. Response of isolated muskrat and guinea pig hearts to hypoxia
82. Developmental changes in ionic channel activity in the embryonic murine heart
83. Adenosine triphosphate-sensitive and inwardly rectifying potassium channels expressed in cardiomyocytes differentiated from embryonic stem cells
84. + channels in the electrical excitability of early embryonic stem cell-derived cardiomyocytes
85. + channel current in atrial myocytes of guinea pig heart
86. + channels in cardiac muscle by the sulphonylurea drug glibenclamide
87. Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim
88. + channels suggest multiple targets for inhibitory drug molecules
89. Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs
90. + channel expressed in a mammalian cell line, HEK293T cells
91. + channels
92. + channels in guinea pig ventricular muscles
93. Effects of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischemia in the arterially perfused interventricular septum of rabbit